[SMLE] LEMS: Clinical Significance of Pathogenic Autoantibodies

[RSS-Bot]

Brain Nerve. 2023 Jul;75(7):837-845. doi: 10.11477/mf.1416202429.

ABSTRACT

Approximately 90% of patients with Lambert-Eaton myasthenic syndrome (LEMS) are positive for P/Q-type voltage-gated calcium channels (VGCCs) antibodies, and can be broadly divided into two groups: paraneoplastic, especially with small cell lung carcinoma and, non-paraneoplastic, without cancer. Under the Japanese LEMS diagnostic criteria 2022, abnormal electrophysiological results is mandatory for diagnosis in addition to muscle weakness. Contrastingly, autoantibodies are useful for diagnosing the etiology and influence treatment strategies. We comprehensively reviewed the MG/LEMS 2022 practice guidelines. Moreover, we presented a case of PCD without LEMS that was positive for P/Q-type VGCCs antibodies_and discussed the clinical significance of the autoantibodies.

PMID:37431074 | DOI:10.11477/mf.1416202429


Source: https://pubmed.ncbi.nlm.nih.gov/3743107 ... t6+86293ac